THORNE HEALTHTECH INC (THRN) Stock Analyst Earnings Estimates
NASDAQ:THRN - Nasdaq - US8852601090 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 138.455M 35.04% | 184.301M 33.11% | 228.731M 24.11% | 294.11M 28.58% | 368.07M 25.15% | 430.37M 16.93% | |
| EBITDA YoY % growth | 5.311M 157.06% | 15.768M 196.92% | 11.305M -28.31% | 31.316M 177.02% | 52.641M 68.10% | 76.086M 44.54% | |
| EBIT YoY % growth | 1.015M 107.30% | 11.315M 1,015.06% | 5.481M -51.56% | 23.828M 334.72% | 48.159M 102.11% | 67.024M 39.17% | |
| Operating Margin | 0.73% | 6.14% | 2.40% | 8.10% | 13.08% | 15.57% | |
| EPS YoY % growth | N/A | N/A | 0.29 64.82% | 0.33 14.31% | 0.62 87.69% | 1.08 73.77% |
All data in USD
| Q3 / 23 | Q4 / 23 | Q1 / 24 | |
|---|---|---|---|
| EPS Q2Q % growth | 0.06 -12.57% | 0.11 -55.38% | 0.12 1,324.00% |
| Revenue Q2Q % growth | 72.944M 24.86% | 79.199M 32.94% | 89.709M 37.51% |
| EBITDA Q2Q % growth | 7.019M -11.75% | 10.722M 17.04% | 11.618M 651.35% |
| EBIT Q2Q % growth | 5.171M 47.11% | 9.033M 170.64% | 9.904M 67,336.93% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 0.08 172.73% | 0.06 | 0.02 | 30.72% |
| Q1 2023 Q2Q % growth | -0.01 -111.11% | 0.08 | -0.09 | -112.25% |
| Q4 2022 Q2Q % growth | 0.24 300.00% | 0.18 | 0.06 | 30.72% |
| Q3 2022 Q2Q % growth | 0.07 600.00% | 0.14 | -0.07 | -50.98% |
| Q2 2022 Q2Q % growth | -0.11 | -0.01 | -0.10 | -2,056.86% |
| Q1 2022 Q2Q % growth | 0.09 | 0.10 | -0.01 | -8.73% |
| Q4 2021 Q2Q % growth | 0.06 | 0.03 | 0.03 | 96.08% |
| Q3 2021 Q2Q % growth | 0.01 | -0.03 | 0.04 | 130.17% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 72.715M 29.69% | 69.829M | 2.886M | 4.13% |
| Q1 2023 Q2Q % growth | 65.238M 19.33% | 67.534M | -2.296M | -3.40% |
| Q4 2022 Q2Q % growth | 59.576M 21.79% | 65.187M | -5.611M | -8.61% |
| Q3 2022 Q2Q % growth | 58.419M 21.68% | 64.709M | -6.29M | -9.72% |
| Q2 2022 Q2Q % growth | 56.068M 30.72% | 58.423M | -2.355M | -4.03% |
| Q1 2022 Q2Q % growth | 54.668M 22.89% | 57.241M | -2.573M | -4.49% |
| Q4 2021 Q2Q % growth | 48.918M -64.67% | 50.059M | -1.141M | -2.28% |
| Q3 2021 Q2Q % growth | 48.01M | 46.257M | 1.753M | 3.79% |
| Q2 2021 Q2Q % growth | 42.89M 41.27% | % | ||
| Q1 2021 Q2Q % growth | 44.484M 34.21% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 5.69% |
| Revenue | 0% | -0.7% | 0% | 1.81% |